TRIDENT LIFELINE
Back to Cashflow Statement
|
TRIDENT LIFELINE Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹20 Cr | ₹11 Cr | ₹42 Cr | ₹0.80 Cr |
What is the latest Cash Flow from Financing Activities ratio of TRIDENT LIFELINE ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹20 Cr |
| Mar2024 | ₹11 Cr |
| Mar2023 | ₹42 Cr |
| Mar2022 | ₹0.80 Cr |
How is Cash Flow from Financing Activities of TRIDENT LIFELINE Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹20 Cr | 79.51 | |
| Mar2024 | ₹11 Cr | -73.97 | |
| Mar2023 | ₹42 Cr | 5,172.19 | |
| Mar2022 | ₹0.80 Cr | - | |
Compare Cash Flow from Financing Activities of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹328.3 Cr | 8% | -9.5% | -12% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,217.0 Cr | 0.4% | 5.6% | 1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹166,047.0 Cr | -0.5% | 3.3% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹148,872.0 Cr | 4.5% | 10% | 41.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹108,454.0 Cr | 1.5% | 4.8% | 9.1% | Stock Analytics | |
| CIPLA | ₹107,136.0 Cr | -1.7% | 1% | -10.5% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | 8% |
-9.5% |
-12% |
| SENSEX | -1.5% |
0.8% |
8.2% |
You may also like the below Video Courses